Central Trust CO Bio Rad Laboratories, Inc. Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$269.37 - $365.04 $3,232 - $4,380	12 New	12 $3,000
Q2 2023 Jul 26, 2023	SELL	$359.49 - $486.4 $38,105 - $51,558	-106 Reduced 82.17%	23 $8,000
Q1 2023 Apr 19, 2023	SELL	$418.69 - $503.0 $2,512 - $3,018	-6 Reduced 4.44%	129 $61,000
Q4 2022 Jan 26, 2023	SELL	$351.71 - $456.01 $138,925 - $180,123	-395 Reduced 74.53%	135 $0
Q3 2022 Nov 17, 2022	SELL	$412.59 - $563.26 $7,839 - $10,701	-19 Reduced 3.46%	530 $221,000
Q2 2022 Aug 09, 2022	BUY	$463.67 - $597.16 $5,100 - $6,568	11 Added 2.04%	549 $272,000
Q1 2022 May 03, 2022	SELL	$524.57 - $735.42 $3,671 - $5,147	-7 Reduced 1.28%	538 $303,000
Q4 2021 Feb 08, 2022	SELL	$708.84 - $794.68 $81,516 - $91,388	-115 Reduced 17.42%	545 $411,000
Q3 2021 Oct 19, 2021	SELL	$657.71 - $825.77 $23,019 - $28,901	-35 Reduced 5.04%	660 $492,000
Q2 2021 Jul 23, 2021	SELL	$576.64 - $649.04 $6,343 - $7,139	-11 Reduced 1.56%	695 $447,000
Q1 2021 Apr 23, 2021	SELL	$547.01 - $662.35 $49,230 - $59,611	-90 Reduced 11.31%	706 $403,000
Q4 2020 Jan 29, 2021	SELL	$510.68 - $643.45 $20,937 - $26,381	-41 Reduced 4.9%	796 $464,000
Q3 2020 Oct 22, 2020	SELL	$454.43 - $535.6 $17,722 - $20,888	-39 Reduced 4.45%	837 $431,000
Q2 2020 Jul 14, 2020	SELL	$334.87 - $493.06 $395,816 - $582,796	-1,182 Reduced 57.43%	876 $395,000
Q1 2020 Apr 17, 2020	SELL	$320.01 - $409.07 $1,280 - $1,636	-4 Reduced 0.19%	2,058 $721,000
Q3 2019 Oct 28, 2019	BUY	$304.55 - $345.24 $621,891 - $704,980	2,042 Added 10210.0%	2,062 $686,000
Q2 2019 Jul 12, 2019	BUY	$286.93 - $312.59 $1,147 - $1,250	4 Added 25.0%	20 $0
Q1 2019 Apr 26, 2019	BUY	$224.3 - $317.41 $3,588 - $5,078	16 New	16 $0

Others Institutions Holding BIO

# of Institutions

459

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.1B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account